We discover and deliver next generation cell medicines to improve the lives of patients.
At Clade Therapeutics, we’re shifting the paradigm of cell medicine by establishing a robust cellular platform with stem-cell derived immune cells for treatment of cancer and autoimmune diseases.
Clade has unparalleled expertise in generating adult human T cells, Treg cells and B cells derived from induced pluripotent stem cells (iPSCs). Clade is combining this expertise with its proprietary immune “cloaking” of human iPSCs and their adult derivatives, novel universal targeting, and cellular enhancements to enable the development of true “off-the-shelf” cell therapies.
Clade is a leading innovator in developing engineerable, off-the-shelf, scalable, and consistent cell medicines.